Prediction Case File
YouTubeEvaluation Complete

Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community

1 extracted signal · 1 resolved · 0 still active

Parkev Tatevosian, CFA profile imageParkev Tatevosian, CFA20 Aug 2025, 12:30 UTC
Video preview for Membership: Join my YouTube channel membership and unlock exclusive perks! As a member, you'll get early access to videos to stay ahead with the latest content before anyone else. Investor tier members get access to my spreadsheets, and VIP discord members get access to our private discord community
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

The video analyzes UNH, stating its current price at $271.49 but calculating its intrinsic value at $430, implying it is undervalued. It mentions Warren Buffet's Berkshire Hathaway taking a stake, increasing shares by 10%. The presenter considers a higher than average risk with UnitedHealth group estimating a cost of 6.5 billion dollars in 2025 and adjusting the risk measure for the company's shares and the weighted average cost of capital is 10.4%. Free cash flow is expected at $375 billion.The analysis also estimates Novo Nordisk's intrinsic value per share at $127, while its current market price is $51.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  6. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

Parkev Tatevosian, CFA

Tracked signals
1097
Historical success
24.1%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.